Recce Pharmaceuticals Ltd.ASX: RCE

Retirement of Mr Alistair McKeough as Non-Executive Director

· Issued by Recce Pharmaceuticals Ltd. via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Recce Pharmaceuticals Ltd. announces the retirement of Mr. Alistair McKeough as Non-Executive Director, effective after the upcoming Annual General Meeting. Mr. McKeough will not seek re-election, and the related resolution has been withdrawn from the AGM agenda. Dr. Alan Dunton will take over as Chair of the Audit and Risk Committee following the AGM. The announcement highlights Mr. McKeough's contributions and the company's focus on developing anti-infectives.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX Announcement Retirement of Non-Executive Director SYDNEY Australia, 4 November 2026: Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company or Recce), a leading developer of a new class of Synthetic Anti-infectives, advises that Mr Alistair McKeough, Independent Non-Executive Director, has...

Recce Pharmaceuticals Ltd. on 6ix

In the deck

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases